Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00049283What this trial is testingErlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the Larynx+24 more National Cancer Institute (NCI) 30
Not applicableStudy completedNCT01487733What this trial is testingBiomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301Who this might be right forHead and Neck Cancer Eastern Cooperative Oncology Group 155
Testing effectiveness (Phase 2)Looking for participantsNCT06532279What this trial is testingTesting the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck CancerWho this might be right forClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+38 more NRG Oncology
Testing effectiveness (Phase 2)Study completedNCT00114283What this trial is testingLapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck CancerWho this might be right forRecurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+31 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT07121595What this trial is testingPersonalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT TrialWho this might be right forOral Cavity Squamous Cell CarcinomaStage I Lip and Oral Cavity Cancer AJCC v8Stage II Lip and Oral Cavity Cancer AJCC v8+2 more University of Michigan Rogel Cancer Center 50
Early research (Phase 1)Study completedNCT01637194What this trial is testingCetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck CancerWho this might be right forRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Colon Cancer+46 more Fox Chase Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT01469429What this trial is testingPhase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.Who this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage 0 Hypopharyngeal Cancer+55 more Ohio State University Comprehensive Cancer Center 70
Early research (Phase 1)Ended earlyNCT01528137What this trial is testingTalactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+43 more Stanford University 4
Early research (Phase 1)Study completedNCT02035527What this trial is testingSorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more Ohio State University Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)WithdrawnNCT01465815What this trial is testingPhase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)Who this might be right forRecurrent Skin CancerRecurrent Squamous Cell Carcinoma of the Lip and Oral CavitySquamous Cell Carcinoma of the Skin+3 more OHSU Knight Cancer Institute
Not applicableStudy completedNCT01619618What this trial is testingStudying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 TrialWho this might be right forHead and Neck Cancer Eastern Cooperative Oncology Group 183
Early research (Phase 1)Study completedNCT00006981What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced CancerWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02007200What this trial is testingSoy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing SurgeryWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+28 more National Cancer Institute (NCI) 55
Not applicableStudy completedNCT01466257What this trial is testingBiomarkers in Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer ECOG-ACRIN Cancer Research Group 70
Not applicableStudy completedNCT01466244What this trial is testingBiomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397Who this might be right forHead and Neck Cancer Eastern Cooperative Oncology Group 42
Testing effectiveness (Phase 2)Study completedNCT00033618What this trial is testingIxabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and NeckWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+31 more National Cancer Institute (NCI) 144
Testing effectiveness (Phase 2)Study completedNCT01256385What this trial is testingTemsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous TherapyWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+33 more National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)Study completedNCT01806675What this trial is testing18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT00063895What this trial is testingErlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckWho this might be right forRecurrent Non-small Cell Lung CancerRecurrent Ovarian Epithelial CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+27 more National Cancer Institute (NCI) 80